CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-02-25 | Saks Samuel R Director | Grant or award · Stock Option | +5,000 | 5,000 | ||
| 2015-02-25 | Saks Samuel R Director | Grant or award · Restricted Stock Unit | +6,000 | 6,000 | ||
| 2015-02-25 | GRACE PATRICK P Director | Grant or award · Stock Option | +5,000 | 5,000 | ||
| 2015-02-25 | GRACE PATRICK P Director | Grant or award · Restricted Stock Unit | +6,000 | 6,000 | ||
| 2015-02-09 | MARIO ERNEST Director | Purchase | +30,000 | $5.85 | $176K | 196,472 |
| 2015-02-09 | LEDERMAN SETH Chief Executive Officer | Purchase | +5,000 | $5.85 | $29K | 55,074 |
| 2015-02-09 | GERSHELL LELAND Chief Financial Officer | Purchase | +5,000 | $5.85 | $29K | 17,860 |
| 2014-12-18 | MARIO ERNEST Director | Option exercise | +30,000 | $4.25 | $128K | 166,472 |
| 2014-12-18 | MARIO ERNEST Director | Option exercise · Series A common stock purchase warrant | −30,000 | 0 | ||
| 2014-12-17 | GERSHELL LELAND Chief Financial Officer | Option exercise | +3,530 | $4.25 | $15K | 12,860 |
| 2014-12-17 | GERSHELL LELAND Chief Financial Officer | Option exercise · Series A common stock purchase warrant | −3,530 | 0 | ||
| 2014-10-29 | Rhodes John B Director | Grant or award · Stock Option | +7,500 | 7,500 | ||
| 2014-10-29 | KELLERMAN DONALD J See Remarks | Grant or award · Stock Option | +36,000 | 36,000 | ||
| 2014-10-29 | MATHER CHARLES E IV Director | Grant or award · Stock Option | +5,000 | 5,000 | ||
| 2014-10-29 | GRACE PATRICK P Director | Grant or award · Stock Option | +5,000 | 5,000 | ||
| 2014-10-29 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +26,500 | 26,500 | ||
| 2014-10-29 | DAUGHERTY BRUCE See Remarks | Grant or award · Stock Option | +36,000 | 36,000 | ||
| 2014-10-29 | GERSHELL LELAND Chief Financial Officer | Grant or award · Stock Option | +38,000 | 38,000 | ||
| 2014-10-29 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2014-10-29 | LANDRY DONALD W Director | Grant or award · Stock Option | +5,000 | 5,000 |
Page 20 of 25 · 482 trades